Sneaky Bacteria Change Key Protein's Shape to Escape Detection

Article

Every once in a while in the U.S., bacterial meningitis seems to crop up out of nowhere, claiming a young life. Part of the disease's danger is the ability of the bacteria to evade the body's immune system, but scientists are now figuring out how the pathogen hides in plain sight. Their findings, which could help defeat these bacteria and others like it, appear in the Journal of the American Chemical Society.

Linda Columbus and colleagues explain that the bacteria Neisseria meningitidis, one cause of meningitis, and its cousin Neisseria gonorrhoeae, which is responsible for gonorrhea, have key-like proteins that allow them to enter human cells and do their damage. Gonorrhea can be cured, though one type of the responsible bacteria has reached "superbug" status, becoming resistant to known drugs. If meningitis is not treated immediately with antibiotics, it can cause severe disability and death. In a search for new ways to treat these diseases, scientists are looking more closely at how the bacteria sneak around in the body undetected. When someone gets an infection, specific proteins - called antigens - that stud the pathogen's outer layer usually raise an alarm, and the body's immune system goes on the attack. But these two kinds of Neisseria bacteria can elude the body's look-out cells, and Columbus' team wanted to know how.

They combined two approaches to figure out the architecture of one of the bacteria's outer proteins that help it gain entry into human cells. They found that the protein's outer loops that jostle against each other, causing their structure to constantly change. This shape-shifting makes for a kind of camouflage that hides them from the body's sentinels, at the same time preserving its ability to bind to and enter a person's cells. This deeper understanding could help lead to new treatments for bacterial diseases, the scientists state.

The authors acknowledge funding from the National Science Foundation, Cottrell Scholar Award, the University of Virginia nanoSTAR and the National Institutes of Health.

Source: American Chemical Society

Recent Videos
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Related Content